Evidence map›Paper›PMID 28639122›Full record

ArticleMolecular imaging and biology2017

Targeting Prostate-Specific Membrane Antigen (PSMA) with F-18-Labeled Compounds: the Influence of Prosthetic Groups on Tumor Uptake and Clearance Profile.

Vincent Bouvet, Melinda Wuest, Justin J Bailey, Cody Bergman, Nancy Janzen, John F Valliant, Frank Wuest

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular imaging and biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Chemoenzymatic Syntheses of Fluorine-18-Labeled Disaccharides from [Journal of the American Chemical Society · 2023
    Article
  3. ACS medicinal chemistry letters · 2023
    Article
  4. Article
  5. Article
  6. Sweetening Pharmaceutical Radiochemistry byPharmaceuticals (Basel, Switzerland) · 2021
    Review
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Vincent BouvetDepartment of Oncology, University of Alberta, Cross Cancer Institute, 11560 University Avenue, Edmonton, AB, T6G 2X4, Canada.
Melinda WuestDepartment of Oncology, University of Alberta, Cross Cancer Institute, 11560 University Avenue, Edmonton, AB, T6G 2X4, Canada.
Justin J BaileyDepartment of Oncology, University of Alberta, Cross Cancer Institute, 11560 University Avenue, Edmonton, AB, T6G 2X4, Canada.
Cody BergmanDepartment of Oncology, University of Alberta, Cross Cancer Institute, 11560 University Avenue, Edmonton, AB, T6G 2X4, Canada.
Nancy JanzenDepartment of Chemistry and Chemical Biology, McMaster University, 1280 Main St., Hamilton, ON, L8S 4K1, Canada.
John F ValliantDepartment of Chemistry and Chemical Biology, McMaster University, 1280 Main St., Hamilton, ON, L8S 4K1, Canada.
Frank WuestDepartment of Oncology, University of Alberta, Cross Cancer Institute, 11560 University Avenue, Edmonton, AB, T6G 2X4, Canada. wuest@ualberta.ca.

Funding

CIHR
6 · The paper itself

Abstract

purposeProstate-specific membrane antigen (PSMA) is an important biomarker expressed in the majority of prostate cancers. The favorable positron emission tomography (PET) imaging profile of the PSMA imaging agent 2-(3-(1-carboxy-5-[(6-[ PROCEDURES: Prosthetic groups N-succinimidyl-4-[

resultsF-18-labeled PSMA inhibitors were synthesized in 32-69 % radiochemical yields using (1) acylation reaction at the primary amino group of the lysine residue with [

conclusionThe observed tumor uptake and clearance profiles demonstrate the importance of the selected prosthetic group on the pharmacokinetic profile of analyzed PSMA-targeting radiotracers. Radiotracer [

Indexed as

AnimalsCell Line, TumorFluorine RadioisotopesInhibitory Concentration 50MaleMice, Inbred BALB CPositron-Emission TomographyProstate-Specific AntigenProstatic NeoplasmsTime FactorsFluorine RadioisotopesProstate-Specific AntigenF-18Positron emission tomography (PET)Prostate cancerProstate-specific membrane antigen (PSMA)

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.